Simulations
malaria
MALARIA
Simulations of the final survival models revealed that by 24 months of age, stunted children without chemoprevention were predicted to experience one additional malaria episode compared with children with a ZHA of zero (Table Number of malaria episodes for stunted and non‐stunted children by piperaquine concentration
Abbreviations: DP, dihydroartemisinin‐piperaquine; TS, trimethoprim‐sulfamethoxazole.When quantifying the impact of malaria on height and ZHA from 6 months to 3 years of age, we simulated populations with no malaria episodes, five episodes, 11 episodes, and 17 episodes. Compared with children with no malaria episodes there was a 1.3%, 3.2%, or 5.2% increase in the number of stunted children if children developed 5, 11, or 17 malaria episodes, respectively (Figure 